Nicardipine in the Treatment of Raynaud's Phenomenon: A Randomized Double-Blind Trial

Kahan, André; Amor, Bernard; Menkès, Charles J.; Weber, Simon; Guérin, Francois; Degeorges, Michel
April 1987
Angiology;Apr1987, Vol. 38 Issue 4, p333
Academic Journal
The efficacy of the calcium-channel blocker nicardipine in the treatment of Raynaud's phenomenon was assessed in a prospective, double-blind, randomized, crossover trial in 20 patients. Each patient received nicardipine 20 mg or placebo three times a day for two weeks and then was crossed over for two weeks. Nicardipine significantly decreased the frequency and severity of Raynaud's phenomenon as compared with placebo. The authors conclude that nicardipine is effective in the treatment of Raynaud's phenomenon.


Related Articles

  • Application of Grey Relational Analysis to Hypertension Clinical Trials. Pan Hong-xing; Tan Xue-rui // Journal of Grey System;2007, Vol. 19 Issue 2, p125 

    It has become very important to choose the appropriate clinical trial method. In current randomized clinical trials of hypertension, however, there are some flaws including ethical issues, long time, huge expenses, excessive confounding factors and difficult quality control. The application of...

  • Understanding and Harnessing Placebo Effects: Clearing Away the Underbrush. MILLER, FRANKLIN G.; BRODY, HOWARD // Journal of Medicine & Philosophy;Jan2011, Vol. 36 Issue 1, p69 

    Despite strong growth in scientific investigation of the placebo effect, understanding of this phenomenon remains deeply confused. We investigate critically seven common conceptual distinctions that impede clear understanding of the placebo effect: (1) verum/placebo, (2) active/inactive, (3)...

  • Evaluation of Drug Toxicity in Clinical Trials. Spławiński, Jacek; Kuźniar, Jerzy; Filipiak, Krzysztof; Zieliński, Waldemar // Science & Engineering Ethics;Jan2006, Vol. 12 Issue 1, p139 

    An increasing number of drugs removed from the market because of unacceptable toxicity raises concerns regarding preapproval testing of drug safety. In the present paper it is postulated that the non-inferiority type of trial should be abandoned in favor of the superiority trial with active...

  • The Two Period Crossover Design in Medical Research. Woods, John R.; Williams, James G.; Tavel, Morton // Annals of Internal Medicine;4/1/89, Vol. 110 Issue 7, p560 

    Deals with the two-period crossover design in medical research. Features of the crossover design; Advantages of the crossover design; Deficiencies of the crossover design; Clinical sources of confounding in crossover designs.

  • Pharmacological treatments of cerebellar ataxia. Ogawa, Masafumi // Cerebellum;Jun2004, Vol. 3 Issue 2, p107 

    The confirmed pharmacological treatment of cerebellar ataxia is still lacking. In a recent preliminary trial, we showed that D-cycloserine, a partial NMDA allosteric agonist, may relieve the symptoms. In this paper, major clinical trials to relieve ataxic symptoms are reviewed. Previous studies...

  • The Acute Effect of Acupuncture on Endothelial Dysfunction in Patients with Hypertension: A Pilot, Randomized, Double-Blind, Placebo-Controlled Crossover Trial. Jung-Mi Park; Ae-Sook Shin; Seong-Uk Park; Il-Suk Sohn; Woo-Sang Jung; Sang-Kwan Moon // Journal of Alternative & Complementary Medicine;Aug2010, Vol. 16 Issue 8, p883 

    Objectives: The objective of the study was to test whether acupuncture improves endothelial dysfunction in patients with hypertension and compare the effects of different acupoints to find out which one is the most suitable for the long-term follow-up study. Design: This study is a pilot,...

  • Characteristic and incidental (placebo) effects in complex interventions such s acupuncture. Paterson, Charlotte; Dieppe, Paul // BMJ: British Medical Journal (International Edition);5/21/2005, Vol. 330 Issue 7501, p1202 

    Reports on the use of randomised double blind controlled trials for characteristic and incidental effects in complex medical interventions. Assumptions that underlie the design of randomised controlled trials; Types of factors that are defined as incidental and characteristic; Description of...

  • Is the Placebo powerless? An analysis of clinical trials comparing placebo with no treatment. Hróbjartsson, Asbjørn; Gøtzsche, Peter C. // Advances in Mind-Body Medicine;Fall2001, Vol. 17 Issue 4, p292 

    The article presents information on the research paper "Is the Placebo powerless? An analysis of clinical trials comparing placebo with no treatment," conducted by the authors. According to the authors, they found little evidences in support of the belief that placebos have powerful clinical...

  • STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study. von Arnim, Ulrike; Peitz, Ulrich; Vinson, Bettina; Gundermann, Karl-Josef; Malfertheiner, Peter // American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1268 

    BACKGROUND: Functional dyspepsia (FD) constitutes a complex picture with a variety of epigastric symptoms. No standard therapy is currently available for FD. OBJECTIVE: This multicenter, placebo-controlled, double-blind study evaluated the efficacy and tolerability of the herbal drug STW 5,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics